Pharmaceutical manufacturing

FILE - In this Monday, April 13, 2015 file photo, Britain's Prince Andrew visits the AkzoNobel Decorative Paints facility in Slough, England. Prince Andrew's effort to put the Jeffrey Epstein scandal behind him may have instead done him irreparable harm. While aides are trying to put the best face on his widely criticized interview with the BBC, royal watchers are asking whether he can survive the public relations disaster and remain a working member of the royal family. (David Parker/Pool Photo via AP, File)
November 19, 2019 - 8:12 am
LONDON (AP) — Britain’s Prince Andrew is facing further disgrace as charitable backers begin to distance themselves from him amid unfavorable fallout of an interview on his friendship with sex offender Jeffrey Epstein. Britain’s Press Association is reporting that professional services provider...
Read More
November 18, 2019 - 5:36 pm
WASHINGTON (AP) — In a story Nov. 18 about the White House push for prescription drug legislation, The Associated Press misspelled the first name of the executive director of Families USA. The correct spelling is Frederick, not Frederic. A corrected version of the story is below: Drug cost...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 18, 2019 - 3:22 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 17, 2019 - 10:16 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 17, 2019 - 7:55 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
FILE - This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Thursday, Nov. 14, 2019, government health advisers recommended broader use of the prescription-strength fish oil drug to prevent heart attack, stroke and other life-threatening health problems. (Amarin via AP)
November 14, 2019 - 6:17 pm
WASHINGTON (AP) — Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems. Currently the drug, Vascepa, is approved for a relatively narrow group of patients with...
Read More
House Speaker Nancy Pelosi of Calif., speaks during a news conference on Capitol Hill in Washington, Thursday, Oct. 31, 2019. (AP Photo/Susan Walsh)
November 05, 2019 - 1:13 pm
WASHINGTON (AP) — The White House has concluded that House Speaker Nancy Pelosi's plan authorizing Medicare to negotiate drug prices is "unworkable" and President Donald Trump will instead support bipartisan legislation in the Senate, a senior White House official said Tuesday. Despite the House...
Read More
House Speaker Nancy Pelosi of Calif., speaks during a news conference on Capitol Hill in Washington, Thursday, Oct. 31, 2019. (AP Photo/Susan Walsh)
November 05, 2019 - 12:27 pm
WASHINGTON (AP) — The White House says House Speaker Nancy Pelosi's plan authorizing Medicare to negotiate prescription drug prices is "unworkable" and President Donald Trump is instead supporting bipartisan Senate legislation. A senior White House official tells The Associated Press the...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 5:53 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check. Companies have largely...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 4:56 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check following a mixed report...
Read More

Pages